Meng Xu

机构：Guangdong Province Stomatological Hospital, Guangdong Provincial Occupational Disease Prevention Hospital, Key Laboratory of Guangdong Province, Shanghai University of Traditional Chinese Medicine, Gansu Provincial Hospital, Stomatology Hospital, Shanghai Traditional Chinese Medicine Hospital, Guangdong Provincial Center for Disease Control and Prevention, First Affiliated Hospital of Jinan University · ORCID：0000-0002-4470-8815

发表论文 18 篇 · 总被引 184 次 · h-index 6

代表论文

• A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma (2022 · Frontiers in Oncology · 被引 82)
• Role of αVβ3 in Prostate Cancer: Metastasis Initiator and Important Therapeutic Target (2020 · OncoTargets and Therapy · 被引 32)
• EBF1-mediated up-regulation of lncRNA FGD5-AS1 facilitates osteosarcoma progression by regulating miR-124-3p/G3BP2 axis as a ceRNA (2022 · Journal of Orthopaedic Surgery and Research · 被引 19)
• Interleukin‑8 promotes prostate cancer bone metastasis through upregulation of bone sialoprotein (2019 · Oncology Letters · 被引 10)
• Systemic inflammatory response index is a predictor of prognosis in gastric cancer patients: Retrospective cohort and meta-analysis (2024 · World Journal of Gastrointestinal Surgery · 被引 8)
• A Nomogram Based on Preoperative Clinical Bio-Indicators to Predict 5-year Survivals for Patients with Gastric Cancer After Radical Gastrectomy (2020 · Cancer Management and Research · 被引 8)